You are here

The programme is an ESO recommended activity and is held with the support of

The SIOG Advanced Course in Geriatric Oncology is our unique CME accredited training programme lead by international experts in the field of geriatrics AND oncology designed to provide specific skills in assessment, care pathways and therapeutic choices about the elderly patients with cancer in order to provide the basis of the assessment and the multi-dimensional approach that should be applied to elderly cancer patients.

This 2-phase advanced course is addressed to professionals in the management of elderly cancer patients who will acquire knowledge on the general principles of cancer treatment as a multidisciplinarity with case based programmes, discussions and debates in geriatrics for clinical oncologists as well as in clinical oncology for geriatricians.

Course dates

Phase 1 - 4-day course in Treviso, Italy from June 29-July 2, 2016
Phase 2 - this phase consists in attending the SIOG 3-day Annual Conference, to be held in 2016 in Milan (Italy) from November 17-19, and it will end with a follow-up and wrap-up session with faculty

University Certificate will be provided to students only at the end of phase II on the proviso of attendance to both phases. 

Academic year: 2016

Location of the course

Phase 1 - Università Cattolica del Sacro Cuore - Centro Studi Achille e Linda Lorenzon - Viale G. Oberdan 5, 31100 Treviso, Italy. (website of the university)
Phase 2 – Milan Marriott Hotel, Via Washington, 66, 20146 Milano, Italy -

Purpose of the course

The course aims are:

  1. To provide basic information related to cancer medicine to the geriatricians and to the application of geriatric principles to the clinical oncologists
  2. To train young medical oncologists and geriatricians to work together. These individuals will become the bridge between the oncological and geriatric teams in their own institutions

The course is addressed at:

  • Medical oncologists completing their training since less than 5 years and medical oncology fellows
  • Other clinical oncologists: surgical oncologists and radiotherapists completing their training since less than 5 years and radiotherapy fellows
  • Geriatricians completing their training since less than 5 years and geriatric fellows

For further information please do not hesitate to contact: SIOG Head Office at

Endorsed by


Under the auspices of

Scientific programme committee

Course director
Silvio Monfardini (IT)

Course coordinator
Giuseppe Colloca (IT)

Riccardo Audisio (GB),
Etienne Brain (FR),
Giuseppe Colloca (IT),
Silvio Monfardini (IT),
Pierre Soubeyran (FR),
Laurence Verhagen (CH) – ex-officio

Course programme & faculty

The course consists in a common part addressed to both Clinical Oncologists and Geriatricians and two other successive parts for Clinical Oncologists on one side and on the other side for Geriatricians. Case presentation and discussion are in common.
The course faculty will take care of the case selection and their presentations, subdivision of the participants in 4-5 small groups, and to follow their internal analysis of the case, before presentation of the conclusions in the general discussion.
The teachers are continuously present during the course and remain available as individual mentors, if requested, during the course and thereafter to determine whether there has been development of multidisciplinary treatment teams in each participant's institution within one year and vitality of these teams at five years.


PDF of the final course programme PDF iconSIOG 2016 Advanced Course final programme.pdf

Endorsed by


Under the auspices of

Course faculty list

Matti Aapro (CH)Arti Hurria (US)
Riccardo Audisio (GB)Laura Lozza (IT)
Umberto Basso (IT)Andrea Luciani (IT)
Etienne Brain (FR)Silvio Monfardini (IT)
Antonella Brunello (IT)Siri Rostoft (NO)
Giuseppe Colloca (IT)Pierre Soubeyran (FR)
Marije E Hamaker (NL)Tanya Wildes (US)


Course faculty brief profiles and pictures

Matti Aapro

Clinique de Genolier, Genolier (CH)

Matti Aapro is presently Dean of the Multidisciplinary Oncology Institute, Genolier, Switzerland. He coordinates the SPCC programme of the European School of Oncology (ESO) and serves the International Society for Geriatric Oncology (SIOG) as Executive Board member.  He has been member of the Board of EORTC and ESMO. He is past-President of the Multinational Association for Supportive Care in Cancer (MASCC), is now on its Board of Directors for 2014-2016, and is appointed Co-Chair of MASCC’s Antiemetic Study Group, effective June 2014.
He is Editor-in-Chief of Critical Reviews in Oncology/Hematology, associate editor for the geriatric section of the Oncologist and founding editor of the Journal of Geriatric Oncology (JGO). He is past Associate Editor for Annals of Oncology. He directs the website. He has authored more than 250 publications and his major interests are new drug development, breast cancer, supportive care, and cancer in the elderly. Dr Aapro is Doctor Honoris Causa of the University of Tampere  (2013) and has received the 2010 Acta Oncologica Award and the 2012 ASCO B.J. Kennedy prize.


Riccardo Audisio

University of Liverpool, St Helens Teaching Hospital, St Helens (GB)

Riccardo A. Audisio was born in Milan, Italy and graduated in Padua (1980): he specialised in General Surgery (1985) and Diagnostic Radiology (1994).
Trained at the National Cancer Institute of Milan (1980-94) he was appointed deputy director at the Department of General Surgery, European Institute of Oncology, Milan (1994-8).
He moved to the United Kingdom in 1999 to become Consultant Surgical Oncologist and Honorary Professor at the University of Liverpool, UK.
Past Editor of Surgical Oncology, Elsevier Publisher (2007-13) he is Editor-in-Chief of the European Journal of Surgical Oncology. Author of 220 peer-reviewed publications and 36 book chapters, Professor Audisio edited 20 book projects and is guest reviewer to 39 international scientific journals.
Professor Audisio is past-president of BASO (British Association of Surgical Oncologists) and president of ESSO (European Society of Surgical Oncology). He is serving as an advisor to the Department of Health and to the All Party Parliamentary Group on Breast Cancer in Older Women. Professor Audisio sits on the Board of Directors of ECCO, the European CanCer Organisation. He is member of several international scientific societies including BASO, ESSO, SSO, ASGBI, ASCRS, AAA, SIOG and EUSOMA. He is past-chair of the Education & Training Committee of ESSO. His clinical research focuses on Breast Cancer and Geriatric Oncology. Past-President of SIOG (International Society of Geriatric Oncology) and past-chair the Surgical Task Force, Professor Audisio has organised several international advanced courses/meeting on cancer surgery, breast cancer and geriatric-oncology.


Umberto Basso

Istituto Oncologico Veneto IOV IRCCS, Padova (IT)

Dr Umberto Basso graduated in Medicine at the University of Padova in 1995, and then specialized in Medical Oncology in 2000 at the same University.
He  is currently full-time Medical Oncologist and Chief of the Genito-Urinary program at  Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
Dr Umberto Basso has published several articles in the field of urological malignancies, soft tissue sarcomas, breast cancer and cancer in the elderly in general, and is has been involved in several phase II and phase III clinical trials in genito-urinary cancer and sarcomas.
He is full member of European Society for Medical Oncology (ESMO), American Society of Medical Oncology (ASCO), and Associazione Italiana di Oncologia Medica (AIOM).


Etienne Brain

Institut Curie - Hôpital René Huguenin, St. Cloud (FR)

Etienne GC Brain, MD PhD, has been working since 1998 as a medical oncologist at the Hôpital René Huguenin (Saint-Cloud, France), which is now part of the academic centre Institut Curie. He obtained both his MD and PhD from University Paris V René Descartes after leading works in preclinical and clinical pharmacology on alkylating agents in Boston (Dana Farber Cancer Institute and Boston University). He was the Deputy Director for Research at Centre René Huguenin from 2008-2009, until the merge with Institut Curie happened in 2010, making this "multi-sites” institution one of the largest one dedicated to breast cancer management in Europe.
Etienne GC Brain is the secretary of the Breast Cancer Group of EORTC and chairs the GERICO group (clinical research in geriatric oncology) at UNICANCER. He is very committed to clinical research, involved in many trials covering breast cancer and geriatric oncology. His most recent interest focuses on competing risks for mortality in older breast cancer patients, trying to better define the indication of systemic treatment in adjuvant setting, and is embodied in the national program ASTER 70s granted in 2011 by the French health ministry. He is (co)author of several publications in peer-reviewed journals, including the JAMA, Lancet Oncol and J Clin Oncol.
He is member of the Editorial Board of the J Geriatric Oncol. He is an active member of ASCO and ESMO. He is the current president of SIOG.


Antonella Brunello

Istituto Oncologico Veneto, Padova (IT)

I am full time consultant at the Division of Medical Oncology 1 at the Istituto Oncologico Veneto in Padova.
I specialized in Medical Oncology in 2008 and I am currently attending the Ph.D Programme in Oncology and Oncological Surgery at the University of Padova. I was an International Visiting Scholar at the Moffit Cancer Center – Senior Adult Oncology Program in the years 2006-2007.
Over my career, I have been committed to medical treatment and clinical research of solid tumors, with particular interest in cancer in the elderly, breast cancer and sarcoma.
I am currently involved as either principal investigator or co-investigator in clinical and translational research projects in oncogeriatric trials.
I authored more than 30 papers in peer-reviewed journals, most of them about breast cancer, sarcoma and cancer in the elderly.
I am serving as scientific secretary of the Hematological Toxicity Guidelines board of the Italian Association of Medical Oncology (AIOM) since 2012.
I am a current member of national and international scientific societies, among which AIOM, ESMO, ASCO, SIOG and I am a board member of the Veneto Regional Section of AIOM, and of the Italian Group for Geriatric Oncology (GioGer).


Giuseppe Colloca

Universita Cattolica Sacro Cuore, (IT)

Giuseppe Colloca is a medical doctor at Policlinico A. Gemelli in Rome, Italy. Graduated in Medicine and Surgery at Catholic University of Sacred Heart of Rome in 2001, after a fellowship in Geriatric Medicine (2006) in the same University, he spent one year in Senior Adult Oncology Group at Moffitt Cancer Center, Florida US and then, in the Palliative Care Unit at  Fundacio’ Hospital Asil de Granollers, Barcellon Spain. In 2014 he completed his PhD in Geriatric-Oncology.  Member of InterRAI group about geriatric assessment tools, his research and clinical interest are on cancer assessment and pain management in the elderly.


Arti Hurria

City of Hope Comprehensive Cancer Care, Duarte, CA (US)

Dr. Arti Hurria is a geriatrician and oncologist and is Director of the Cancer and Aging Research Program at City of Hope. The overall goal of Dr. Hurria’s research program is to improve the care of older adults with cancer. Under Dr. Hurria’s leadership, the Cancer and Aging Research Program has developed and executed over 22 geriatric oncology protocols, enrolling over 3100 participants on studies focused on cancer and aging. Dr. Hurria is principal investigator on 6 NIH-funded grants and has received research support from the Breast Cancer Research Foundation and UniHealth Foundation. Dr. Hurria leads national and international efforts to improve the care of older adults with cancer. She served on the Institute of Medicine, Committee on “Improving the Quality of Cancer Care: Addressing the Challenges in an Aging Population.” Since 2010, Dr. Hurria has served as the Editor-in-Chief for the Journal of Geriatric Oncology. She was the recipient of the B.J. Kennedy Award from the American Society of Clinical Oncology, which recognizes scientific excellence in geriatric oncology. In 2016, Dr. Hurria was elected to the Board of Directors for the American Society of Clinical Oncology.


Marije E Hamaker

Department of Internal Medicine, Diakonessenhuis, Utrecht, (NL)

Marije Hamaker has been working as a clinical geriatrician working at the Diakonessenhuis in Utrecht, the Netherlands since 2010. In 2012, she defended her PhD thesis on “Decision making in geriatric oncology”. She has remained active in geriatric oncology research, focussing on treatment decisions and patient-centred outcome measures in various cancer types, and additionally has set up a project regarding geriatric nephrology in 2014. She is an active member of the Dutch Geriatric Oncology Foundation, the Elderly Task Force of the EORTC as well as a member of SIOG and the Dutch Geriatrics Society.


Laura Lozza

IRCCS Fondazione Istituto Nazionale dei Tumori, Milan (IT)

She is the Head of  the Radiotherapy of Breast Tumors Unit,at the  Fondazione IRCCS Istituto Nazionale Tumori of Milano.
After graduating from medical school at the Università degli Studi di Milano in 1985 ,she was board certified in Radiology and Radiotherapy  from the Università of Milano in 1989.
Visiting fellow  in Radiotherapy at  Stanford University Medical School  in 1992  , member of scientific societies ESTRO , AIRO, EORTC, FONCAM, Senonetwork.

Her  clinical and research experience include breast  cancer  with particolar interest in oncoplastic, adult soft tissue sarcoma, and palliative  radiation treatments   which lead to the publication  as author or co-author author of book chapters and publications in national and international journal and of papers at conferences.
Invited speaker at international conferences and courses, teacher  at refresher courses for continuing education in collaboration with AIRO (Italian Association of Radiation Oncology ) , residential courses of the Italian School of Senology  and European School of Oncology, teacher at  Master of oncoplastic surgery ,  at the School of Specialization in Oncology and Postgraduate School of Physical Medicine and Rehabilitation of the  University of Milan.
Collaborator  in the Research Project aims of the Italian Ministry of Health " Quality Indicators in Radiotherapy "
Adjunct Professor at the School of Specialization in Radiation Therapy , of the Università degli Studi  of Milano since 1999.


Andrea Luciani

The Ospedale S Paolo, Milan (IT)

Andrea Luciani, graduated in Medicine and Surgey at University of Milan. After the fellowship in medical oncology he spent some months in Senior Adult Oncology Group at Moffit Cancer Center, Florida US. When he returned to Italy he took the postdoctoral degree in Pharmacology and Metabolic disease. He is now an assistant physician in medical oncology department at S. Paolo University Hospital in Milan. He is the chairman of EORTC Cancer In the Elderly Task Force and the National Representative for Italy at International Society of Geriatric Oncology (SIOG). He has been the scientific secretary of the AIOM guidelines on elderly cancer patients from 2012 until present. His main interests are cancer in the elderly, with a special focus on lung and genitourinary cancer.

Silvio Monfardini

Instituto Palazzolo,Fondazione  Don Gnocchi, Milan (IT)

Present position: Director Geriatric Oncology Program Istituto Palazzolo, Fondazione Don Gnocchi, Milano, Italy.
Past positions:
Chief of the Division of Medical Oncology of the Istituto Oncologico Veneto of Padua
Scientific Director of the Istituto Nazionale per lo Studio e la Cura dei Tumori of  Naples
Scientific Director of the Centro di Riferimento Oncologico of Aviano
Dr. Silvio Monfardini is the author the main fields of Medical Oncology of 340 indexed publications, of whom 95 dedicated to Geriatric Oncology
Member of the American Society of Clinical Oncology since 1972
Past President of the European Society for Medical Oncology (ESMO)
Past President of the (Associazione Italiana di Oncologia Medica (AIOM)
Past President of the “International Society of Geriatric Oncology” (SIOG)
Recipient in the year 2006 of the International Society of Geriatric Oncology “Paul Calabresi” Memorial lecture award and in 2015 of the B.J. Kennedy award for Geriatric Oncology 


Siri Rostoft

University of Oslo, Norway and City of Hope (NO)

Siri Rostoft is a medical doctor at Oslo University Hospital, Norway, specialized in internal medicine and geriatric medicine. She completed her PhD about geriatric assessment in older surgical cancer patients in 2011. Her main research interests in geriatric oncology are the clinical importance of geriatric assessment and interventions and frailty. She is a deputy editor for Journal of Geriatric Oncology.





Pierre Soubeyran

Institut Bergonie, Bordeaux (FR)

Pierre Soubeyran, M.D., Ph.D., is a Medical Oncologist at Institut Bergonié, Comprehensive Cancer Center in Bordeaux, and Professor of Medical Oncology at the University of Bordeaux. He is highly involved in the development of Geriatric Oncology at both the clinical (co-coordinator of the Coordination Unit of Geriatric Oncology of Aquitaine) and research level (President of the Scientific Council of the French Society of Geriatric Oncology (SoFOG) and Coordinator of the French Geriatric Oncology Cooperative Group DIALOG). He is also involved in cancer research as Director of the U1218 INSERM Cancer research unit and Director of the SIRIC, Center for Integrated Cancer Research of Bordeaux, named BRIO (Bordeaux Recherche Intégrée Oncologie).
He earned his Medical Degree from the University of Nantes in France and trained in Medical Oncology at the Institut Bergonié and University of Bordeaux. He completed a fellowship at the MD Anderson Cancer Center in Houston and later obtained his Ph.D. at the University of Bordeaux in the field of minimal residual disease in follicular lymphoma. An active researcher, Prof. Pierre Soubeyran’s clinical interests include clinical and biological research on lymphoma and geriatric oncology. He is leading trials focused on these topics as part of the French LYSA lymphoma Research Group and the French Geriatric Oncology Cooperative Group DIALOG. He is a member of ESMO, ASCO, ASH, SoFOG and SIOG. He has authored and co-authored numerous articles, book chapters and monographs on various aspects of cancer treatment.


Tanya Wildes

Washington University School of Medicine, St. Louis, MO (US)

Tanya M. Wildes, MD, MSCI is a geriatric oncologist and Assistant Professor of Medicine at Washington University School of Medicine. She completed fellowships in hematology, oncology and geriatrics at Washington University.  Her research and clinical interests focus on older adults with multiple myeloma.  She also studies prevention of falls in older adults with cancer.   She is a member of the Cancer and Aging Research Group, serves as an institutional representative on the National Comprehensive Cancer Network Older Adult Oncology Guidelines panel and is also an active member of SIOG, currently serving as Chair of the Science and Education Committee.

Admission to the course

The admission process for the 2016 Advanced Course is now closed. Should you be interested in attending the 2017 edition (dates to be confirmed), please contact to register your interest.

Ideal profile of the advanced course candidate:

  • Medical oncologists and other clinical oncologists completing their training since less than 5 years and medical oncology fellows
  • Medical oncology fellows
  • Geriatricians completing their training since less than 5 years
  • Geriatric fellows
  • Fluency in English

CME accreditation and diploma

At the end of the course, in accordance with art. 6 of Law no. 341/1990, students will receive a certificate as provided by art. 2, paragraph 5, of Title I of the academic regulations of the University. In accordance with the programme of Continuing Medical Education, the students in a university course are exempted from acquiring the CME credits for the current year (or 50 CME credits).The Catholic University of the Sacred Heart reserves the right to not activate or cancel the course if it does not reach the coverage of expenses.

To obtain the final certification, students are required to attend at least 80% of the teaching and training and the successful completion of all course tests.

The SIOG 2016 Advanced Course in Geriatric Oncology was granted 19 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).

European Accreditation
European Accreditation is granted by the EACCME in order to allow participants who attend the above-mentioned activity to validate their credits in their own country.

Accreditation Statement
Accreditation by the EACCME confers the right to place the following statement in all communication materials including the registration website, the event programme and the certificate of attendance. The following statements must be used without revision:
"The 'International Society of Geriatric Oncoclogy (SIOG)' (or) 'SIOG Advanced Course on Geriatric Oncology' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS),"

"The 'SIOG Advanced Course on Geriatric Oncology' is designated for a maximum of (or 'for up to') 19 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity."

"Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at"

"Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada."

EACCME credits
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

The International Society of Geriatric Oncology thanks all sponsors for their support.


Photo Gallery

Selected photos taken during the SIOG 2016 Advanced Course can be seen here.